Released: February 19, 2015
Department of Defense Ovarian Cancer Research Program
Funding Opportunities for Fiscal Year 2015 (FY15)
The FY15 Defense Appropriations Act provides $20 million (M) to the Department of Defense Ovarian Cancer Research Program (OCRP) to support high-impact ovarian cancer research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate manages and executes the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The executing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
The OCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY15 OCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in March 2015. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government. Funding is contingent on receipt of appropriations.
|Award Mechanism||PI Eligibility||Key Mechanism Elements||Funding|
|Clinical Translational Award||Must be an independent investigator at or above the level of Assistant Professor (or equivalent)||
|Investigator-Initiated Research Award||Must be an independent investigator at or above the level of Assistant Professor (or equivalent)||
|Ovarian Cancer Academy Award - Early-Career Investigator||Early-Career Investigator must be within the first 3 years of his/her first faculty position (or equivalent) at the time of submission. The first faculty position (or equivalent) may be either tenure-track or non-tenure track.
Designated Mentor must be an independent ovarian cancer researcher
|Pilot Award||Investigators at or above the postdoctoral level (or equivalent)||
All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to help@eBRAP.org. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.
For more information about the OCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs